Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...

Broward Health Medical Center is now offering the InterStim X system from Medtronic, a cutting-edge treatment for patients with bladder and bowel control conditions such as urinary and fecal ...

Joseph Welles Henderson, MD, of University Hospitals has been named an InterStim™ Center of Excellence by Medtronic (NYSE: MDT), the world’s largest medical device manufacturer. The designation is ...

Under this partnership, the Minze Diary Pod – an automated bladder diary solution – will be offered as part of the SNM care pathway, enabling clinicians and patients to gather richer, more objective ...

The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive ...

The FDA has issued Medtronic clearance to market the InterStim sacral nerve stimulation therapy system for people with chronic fecal incontinence. The pacemaker-like device has already been FDA ...

Minze Health NV signed a three-year agreement with Medtronic plc to bring its Minze Diary Pod, an app-controlled automated urine collection device, to markets across the EMEA region. The partnership ...

Patients with bladder control symptoms who receive a Medtronic Sacral Neuromodulation Device will now have access to the Minze Diary Pod Under this partnership, the Minze Diary Pod – an automated ...